Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$7.0 - $11.26 $84,924 - $136,606
12,132 New
12,132 $85,000
Q2 2022

Aug 09, 2022

BUY
$20.49 - $39.72 $332,716 - $644,973
16,238 New
16,238 $349,000
Q2 2021

Sep 17, 2021

SELL
$63.02 - $95.11 $253,277 - $382,247
-4,019 Closed
0 $0
Q1 2021

May 19, 2021

BUY
$57.62 - $95.6 $231,574 - $384,216
4,019 New
4,019 $274,000
Q4 2019

Feb 04, 2020

SELL
$19.24 - $28.41 $189,206 - $279,383
-9,834 Closed
0 $0
Q3 2019

Nov 20, 2019

BUY
$20.03 - $40.08 $196,975 - $394,146
9,834 New
9,834 $222,000
Q2 2019

Aug 13, 2019

SELL
$25.78 - $39.77 $913,385 - $1.41 Million
-35,430 Closed
0 $0
Q1 2019

Apr 12, 2019

BUY
$22.09 - $39.21 $782,648 - $1.39 Million
35,430 New
35,430 $1.12 Million
Q2 2018

Jul 30, 2018

SELL
$7.93 - $15.79 $185,244 - $368,854
-23,360 Closed
0 $0
Q2 2018

Jul 30, 2018

BUY
$7.93 - $15.79 $4,932 - $9,821
622 Added 2.74%
23,360 $286,000
Q1 2018

May 14, 2018

BUY
$5.18 - $7.97 $117,782 - $181,221
22,738 New
22,738 $181,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.